Advertisement

Endotoxin-Induced Uveitis in Rodents

  • Umesh C. S. Yadav
  • Kota V. RamanaEmail author
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1960)

Abstract

Uveitis can affect individuals of all ages, genders, and races and accounts for 10–15% of all cases of blindness. Uveitis represents a diverse array of intraocular inflammatory conditions that can be associated with complications from autoimmune diseases, bacterial infections, viral infections, chemical injuries, and metabolic issues. In rodents, endotoxin-induced uveitis (EIU) is an efficient experimental model to study pathological mechanisms associated with the disease and evaluate the pharmacological efficacy of potential new drug agents. In the EIU model, uveitis is characterized by clinically relevant inflammation, including inflammatory exudates and cells infiltrated into the anterior and vitreous eye chambers. EIU in small animal models, including rats, mice, and rabbits, is characterized by a short-lived uveal inflammation. This inflammation can be facilitated using bacterial endotoxins, such as lipopolysaccharide (LPS). In this chapter, we present a reliable, reproducible, and simplified protocol to induce EIU in mice. This method is flexible and can be applied for EIU induction in other small animals and rodents.

Keywords

Endotoxin-induced uveitis Mice Eyes LPS Inflammation 

References

  1. 1.
    de Smet MD, Taylor SR, Bodaghi B et al (2011) Understanding uveitis: the impact of research on visual outcomes. Prog Retin Eye Res 30:452–470CrossRefGoogle Scholar
  2. 2.
    Rathinam SR, Namperumalsamy P (2007) Global variation and pattern changes in epidemiology of uveitis. Indian J Ophthalmol 55:173–183CrossRefGoogle Scholar
  3. 3.
    Nussenblatt RB (1990) The natural history of uveitis. Int Ophthalmol 14:303–308CrossRefGoogle Scholar
  4. 4.
    Read R (2006) Uveitis: advances in understanding of pathogenesis. Curr Rheumatol Rep 8:260–266CrossRefGoogle Scholar
  5. 5.
    Gritz DC, Wong IG (2004) Incidence and prevalence of uveitis in northern California; the northern California epidemiology of uveitis study. Ophthalmology 111:491–500CrossRefGoogle Scholar
  6. 6.
    Rosenbaum JT, McDevitt HO, Guss RB et al (1980) Endotoxin induced uveitis in rats as a model for human disease. Nature 286:611–613CrossRefGoogle Scholar
  7. 7.
    Chatzistefanou K, Markomichelakis NN, Christen W et al (1998) Characteristics of uveitis presenting for the first time in the elderly. Ophthalmology 105:347–352CrossRefGoogle Scholar
  8. 8.
    Yadav UC, Kalariya NM, Ramana KV (2011) Emerging role of antioxidants in the protection of uveitis complications. Curr Med Chem 18:931–942CrossRefGoogle Scholar
  9. 9.
    Altan-Yaycioglu R, Akova YA, Akca S et al (2006) Inflammation of the posterior uvea: findings on fundus fluorescein and indocyanine green angiography. Ocul Immunol Inflamm 14:171–179CrossRefGoogle Scholar
  10. 10.
    Yadav UC, Srivastava SK, Ramana KV (2007) Aldose reductase inhibition prevents endotoxin-induced uveitis in rats. Invest Ophthalmol Vis Sci 48:4634–4642CrossRefGoogle Scholar
  11. 11.
    Yadav UC, Shoeb M, Srivastava SK et al (2011) Aldose reductase deficiency protects from autoimmune- and endotoxin-induced uveitis in mice. Invest Ophthalmol Vis Sci 52:8076–8085CrossRefGoogle Scholar
  12. 12.
    Shen DF, Chang MA, Matteson DM et al (2000) Biphasic ocular inflammatory response to endotoxin-induced uveitis in the mouse. Arch Ophthalmol 118:521–527CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Biochemistry and Molecular BiologyUniversity of Texas Medical BranchGalvestonUSA

Personalised recommendations